Line Uhrenholt
10PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Jul 23, 2024
Exploring TNFi drug-levels and anti-drug antibodies during tapering among patients with inflammatory arthritis: secondary analyses from the randomised BIODOPT trial.Line Uhrenholt, Mads E R Sørensen, Karen B Lauridsen
|Jul 09, 2023
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.Mikkel Østergaard, Ronald F van Vollenhoven, Anna Rudin
|Jun 05, 2023
Predicting successful biologics tapering in patients with inflammatory arthritis: Secondary analyses based on the BIOlogical Dose OPTimisation (BIODOPT) trial.Line Uhrenholt, Kirsten Duch, Robin Christensen
|Feb 06, 2023
Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trial.L Uhrenholt, R Christensen, L Dreyer
|Apr 01, 2022
Isolation in patients with inflammatory rheumatic diseases during COVID-19 pandemic compared to healthy individuals: a questionnaire survey.Tobias Eschricht Eriksen, Wilfred K H Dinesen, Line Uhrenholt
Pageof 2
Frequent Collaborators
5 joint publications
Lene Wohlfahrt Dreyer
5 joint publications
Kirsten S Duch
5 joint publications
Salome Kristensen
4 joint publications
Peter C Taylor
3 joint publications
Robin Christensen
3 joint publications
Ellen-Margrethe Hauge
2 joint publications
Anne Gitte Loft
2 joint publications
Hans Christian Horn
1 joint publications
R D Østgård
1 joint publications
René Cordtz